| Product Code: ETC11877010 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Enteric Disease Testing and Therapeutic Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Enteric Disease Testing and Therapeutic Market - Industry Life Cycle |
3.4 Japan Enteric Disease Testing and Therapeutic Market - Porter's Five Forces |
3.5 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.6 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Enteric Disease Testing and Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of enteric diseases in Japan |
4.2.2 Technological advancements in testing and therapeutic options |
4.2.3 Growing awareness and healthcare infrastructure investment in Japan |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of testing and therapeutic products |
4.3.2 High cost associated with testing and therapeutic procedures |
4.3.3 Limited reimbursement policies for enteric disease treatments |
5 Japan Enteric Disease Testing and Therapeutic Market Trends |
6 Japan Enteric Disease Testing and Therapeutic Market, By Types |
6.1 Japan Enteric Disease Testing and Therapeutic Market, By Testing Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Testing Type, 2021 - 2031F |
6.1.3 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Molecular Testing, 2021 - 2031F |
6.1.4 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Stool Culture, 2021 - 2031F |
6.1.5 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Serological Testing, 2021 - 2031F |
6.1.6 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Rapid Testing Kits, 2021 - 2031F |
6.2 Japan Enteric Disease Testing and Therapeutic Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Gastroenteritis, 2021 - 2031F |
6.2.3 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Cholera, 2021 - 2031F |
6.2.4 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Salmonella Infection, 2021 - 2031F |
6.2.5 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By E. Coli Infection, 2021 - 2031F |
6.3 Japan Enteric Disease Testing and Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.3.4 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.3.5 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Japan Enteric Disease Testing and Therapeutic Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antiviral Therapy, 2021 - 2031F |
6.4.3 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antibiotic Therapy, 2021 - 2031F |
6.4.4 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Probiotic Therapy, 2021 - 2031F |
6.4.5 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Vaccine Therapy, 2021 - 2031F |
6.5 Japan Enteric Disease Testing and Therapeutic Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.4 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.5 Japan Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
7 Japan Enteric Disease Testing and Therapeutic Market Import-Export Trade Statistics |
7.1 Japan Enteric Disease Testing and Therapeutic Market Export to Major Countries |
7.2 Japan Enteric Disease Testing and Therapeutic Market Imports from Major Countries |
8 Japan Enteric Disease Testing and Therapeutic Market Key Performance Indicators |
8.1 Percentage increase in adoption of advanced testing technologies |
8.2 Number of research and development initiatives focused on enteric disease treatments |
8.3 Rate of improvement in patient outcomes post-treatment |
9 Japan Enteric Disease Testing and Therapeutic Market - Opportunity Assessment |
9.1 Japan Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.2 Japan Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Japan Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Japan Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 Japan Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Enteric Disease Testing and Therapeutic Market - Competitive Landscape |
10.1 Japan Enteric Disease Testing and Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Japan Enteric Disease Testing and Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here